Aymes International clinical trials
Aymes International is the lead sponsor of 3 current clinical trials in our UK register. 1 is recruiting patients now. All registered phases are Not applicable. The most-studied condition is Disease Related Malnutrition.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Aymes International
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Tolerance and Acceptability Evaluation of an Oral Nutrition Supplement
NCT07417514 · Disease Related Malnutrition
|
Not applicable | Recruiting | 2022-09 | UK |
|
Tolerance and Acceptability of an Oral Nutrition Supplement
NCT07904715 · Disease Related Malnutrition
|
Not applicable | Not yet open | 2026-11 | UK |
|
Tolerance, Palatability and Acceptability Evaluation of an Oral Nutrition Supplement
NCT07452523 · Disease Related Malnutrition
|
Not applicable | Active, closed | 2022-10 | UK |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Aymes International trials
1 conditionBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in UK | 3 | 1 |
A trial with sites in more than one country appears in each of those registers.
Questions about Aymes International trials
How many clinical trials does Aymes International sponsor?
Aymes International is the lead sponsor of 3 current trials on ClinicalTrials.gov in our UK register, as of the registry sync on 30 October 2026. Completed and withdrawn studies are not counted.
Are Aymes International trials recruiting?
Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 30 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.